Relypsa

Quote
anonymous said:
I love it when that happens too...however I was the one who decided not to interview with this organization. All you needed to see were the clinical differences between Patiromer and ZS9 and that alone would make you do some serious digging which I did.

See post above regarding sales leadership. I'm not making anything up look on Linkedin for yourself and you judge the experience, success and overall accomplishments of this group to lead a start-up with an inferior product in a new market place!!
Click to expand...
 












anonymous said:
Pray tell these "clinical advantages" for ZS-9? Sodium exchange? Adema? Go back to your troll hole....
Click to expand...

If that is all you got you are in worse trouble than I thought..lol.

I don't need to cite the potential clinical advantages here your horrible label highlights them all for the clinical world to see. If this weren't true how did that stock react after the label came out and today compared to prelable news??? LOL THOUGHT SO! Typical pharma rep...
 






anonymous said:
I understand all of that, but there is still plenty of space for two drugs! In light of everything, analysts are still projecting Veltassa to bring in somewhere between $500 million and $1 billion! That's not too shabby considering what I've been selling!
Click to expand...

That were numbers before the label came out. Most have adjusted those figures down post label. I saw a few analysts estimates in the 200MM range.
 












I can't wait for the ZS data to come out to shut everyone up. You will see class labeling and warnings. The same as patiromer. I don't work for either company, however, I do know that the reaction to the stock was misguided. You will see and I will laugh when it comes out
 






anonymous said:
I can't wait for the ZS data to come out to shut everyone up. You will see class labeling and warnings. The same as patiromer. I don't work for either company, however, I do know that the reaction to the stock was misguided. You will see and I will laugh when it comes out
Click to expand...

For the PATIENTS sake I hope you are wrong. Yes, you remember those other people who have skin in the game here the patients right?

Funny how so many pharma types forget about the most important people in all of this and don't realize that their bonus is not the most important part of a new med launching. Spoken like a true pharma rep well done! And we wonder why this industry still has a bad name....

Don't forget Einstein that ZS9 data showed no DDIs in the invivo studies so this is unlikely. Don't hold your breath pigvomit greedy pharma rep.
 


















anonymous said:
Adema or Edema?? Bwahahaha....it's an anonymous post but you still have to feel like a fucking idiot on this one. I pray I'm selling against this jerkoff.
Click to expand...

Holy Crap. This is going to be a disaster. Our reps don't even know how to spell EDEMA. Who in holy hell did we hire? A bunch of Forest and Keryx r*****s?
 






anonymous said:
For the PATIENTS sake I hope you are wrong. Yes, you remember those other people who have skin in the game here the patients right?

Funny how so many pharma types forget about the most important people in all of this and don't realize that their bonus is not the most important part of a new med launching. Spoken like a true pharma rep well done! And we wonder why this industry still has a bad name....

Don't forget Einstein that ZS9 data showed no DDIs in the invivo studies so this is unlikely. Don't hold your breath pigvomit greedy pharma rep.
Click to expand...
 






anonymous said:
For the PATIENTS sake I hope you are wrong. Yes, you remember those other people who have skin in the game here the patients right?

Funny how so many pharma types forget about the most important people in all of this and don't realize that their bonus is not the most important part of a new med launching. Spoken like a true pharma rep well done! And we wonder why this industry still has a bad name....

Don't forget Einstein that ZS9 data showed no DDIs in the invivo studies so this is unlikely. Don't hold your breath pigvomit greedy pharma rep.
Click to expand...
 






anonymous said:
For the PATIENTS sake I hope you are wrong. Yes, you remember those other people who have skin in the game here the patients right?

Funny how so many pharma types forget about the most important people in all of this and don't realize that their bonus is not the most important part of a new med launching. Spoken like a true pharma rep well done! And we wonder why this industry still has a bad name....

Don't forget Einstein that ZS9 data showed no DDIs in the invivo studies so this is unlikely. Don't hold your breath pigvomit greedy pharma rep.
Click to expand...
 






anonymous said:
For the PATIENTS sake I hope you are wrong. Yes, you remember those other people who have skin in the game here the patients right?

Funny how so many pharma types forget about the most important people in all of this and don't realize that their bonus is not the most important part of a new med launching. Spoken like a true pharma rep well done! And we wonder why this industry still has a bad name....

Don't forget Einstein that ZS9 data showed no DDIs in the invivo studies so this is unlikely. Don't hold your breath pigvomit greedy pharma rep.
Click to expand...


Thank God someone gets there is a patient involve.
 






























If you have a phone screen then why would you need the information. If you pass the ph screen you can ask and get accurate info directly from the source.

I will just say the comp plan is extremely generous in many many different areas not just base salary. They are paying for good people however the competition for these positions are extremely strong.
 






anonymous said:
If you have a phone screen then why would you need the information. If you pass the ph screen you can ask and get accurate info directly from the source.

I will just say the comp plan is extremely generous in many many different areas not just base salary. They are paying for good people however the competition for these positions are extremely strong.
Click to expand...

Not so fast, competition for these positions is a fallacy, working here will be with the same old toxic story with the same old toxic people.
 






Top Bottom
Back
Quote